| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00007890-200011150-00015 |
| P698 | PubMed publication ID | 11087152 |
| P50 | author | Yvon Lebranchu | Q33292943 |
| P2093 | author name string | H Ekberg | |
| F Oppenheimer | |||
| Y Vanrenterghem | |||
| R Hené | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cyclosporine | Q367700 |
| P304 | page(s) | 1352-1359 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection | |
| P478 | volume | 70 |
| Q39097285 | A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients |
| Q46452725 | A prospective, randomized, multicenter, double-blind study of early corticosteroid cessation versus long-term maintenance of corticosteroid therapy with tacrolimus and mycophenolate mofetil in primary renal transplant recipients: one year report |
| Q41022599 | Acute Rejection Rates and Graft Outcomes According to Induction Regimen among Recipients of Kidneys from Deceased Donors Treated with Tacrolimus and Mycophenolate |
| Q77369645 | Anti-CD25 prophylaxis allows steroid free kidney transplantation |
| Q43071206 | Anti-interleukin-2 receptor antibodies-basiliximab and daclizumab-for the prevention of acute rejection in renal transplantation |
| Q36765942 | Antihypertensive agents and renal transplantation. |
| Q38047203 | Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation |
| Q83725168 | Comparison of basiliximab and daclizumab with triple immunosuppression in renal transplantation |
| Q37522631 | Corticosteroid minimization in renal transplantation: Careful patient selection enables feasibility |
| Q36441433 | Corticosteroid-sparing strategies in renal transplantation: are we still balancing rejection risk with improved tolerability? |
| Q34439272 | Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation |
| Q37389078 | Dyslipidemia can be controlled in diabetic as well as nondiabetic recipients after kidney transplant |
| Q33708427 | Early outcomes of thymoglobulin and basiliximab induction in kidney transplantation: application of statistical approaches to reduce bias in observational comparisons |
| Q44601996 | Early steroid withdrawal compared with steroid avoidance correlates with graft failure among kidney transplant recipients with an history of diabetes |
| Q35711546 | From cyclosporine to the future |
| Q55385803 | Graft outcomes following immunosuppressive therapy with different combinations in kidney transplant recipients: a nationwide cohort study. |
| Q37764468 | Hypertension in the kidney transplant recipient. |
| Q42679476 | Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy. |
| Q34613091 | Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection |
| Q35682221 | Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance |
| Q43640092 | Is complete avoidance of calcineurin inhibitors or steroids now possible? Importance of patient selection and choice of regimen |
| Q37397103 | Kidney transplant half-life (t[1/2]) after rapid discontinuation of prednisone. |
| Q43518477 | Lessons from cyclosporine monotherapy in renal transplantation: the impact of acute rejection on long-term allograft outcome |
| Q45023761 | Long-term immunosuppression, without maintenance prednisone, after kidney transplantation |
| Q41699763 | Long-term study of steroid avoidance in renal transplant patients: a single-center experience. |
| Q90428781 | Low-dose Rituximab and Thymoglobulin Induction With Steroid-free Maintenance Immunosuppression and Protocol Biopsies Improves Long-term Patient and Graft Survival After Kidney Transplantation: Survival and Safety Outcomes in More Than 1100 Patients |
| Q45175622 | MYSS: should we alter clinical practice? |
| Q46356692 | Maintenance immunosuppressive therapy in adult renal transplantation: a single center analysis. |
| Q46285358 | Mineral and bone disorder is temporary in patients treated with early rapid corticosteroid reduction after kidney transplantation: a single-center experience |
| Q46387298 | Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival. |
| Q37228814 | Minimization of steroids in kidney transplantation |
| Q43158054 | Moving Beyond Minimization Trials in Kidney Transplantation |
| Q44339726 | Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil |
| Q34774048 | Mycophenolate mofetil: a pharmacoeconomic review of its use in solid organ transplantation |
| Q34607590 | Mycophenolate mofetil: safety and efficacy in the prophylaxis of acute kidney transplantation rejection |
| Q73934839 | Overcoming toxicities: new regimens |
| Q36752004 | Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation. |
| Q40441944 | Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial |
| Q42169486 | Randomized trial of tacrolimus versus cyclosporine in steroid withdrawal in living donor renal transplant recipients |
| Q44053026 | Rapid discontinuation of steroids in living donor kidney transplantation: a pilot study |
| Q38187176 | Recollective homeostasis and the immune consequences of peritransplant depletional induction therapy |
| Q37184172 | Renal transplantation with early steroid withdrawal |
| Q41043157 | Risk factors and incidence for lipid abnormalities in kidney transplant patients. |
| Q44101530 | Risk of adrenal insufficiency with steroid maintenance therapy in renal transplantation |
| Q37858189 | Steroid and calcineurin inhibitor-sparing protocols in kidney transplantation |
| Q24240985 | Steroid avoidance or withdrawal for kidney transplant recipients |
| Q43992370 | Steroid withdrawal after renal transplantation--risks and benefits |
| Q36246782 | Steroid withdrawal after renal transplantation: a retrospective cohort study. |
| Q36009635 | Steroid withdrawal in pediatric and adult renal transplant recipients |
| Q43828496 | Steroid withdrawal in renal transplantation |
| Q30823588 | Steroid withdrawal increases risk of acute rejection but reduces infection: a meta-analysis of 1681 cases in renal transplantation |
| Q77369724 | Steroid-free immunosuppression |
| Q34719096 | Steroid-free immunosuppression in kidney transplantation: an editorial review |
| Q37318299 | Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? |
| Q44844488 | Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study |
| Q44101538 | Successful steroid withdrawal at the end of the 1st year after renal transplantion in mycophenolate mofetil-treated patients. |
| Q34459657 | Tailoring immunosuppressive therapy for renal transplant recipients |
| Q35088005 | Tailoring of minimal immunosuppression long term |
| Q35827303 | Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation |
| Q51916897 | Therapeutic drug monitoring of mycophenolic acid in kidney transplant patients: a abbreviated sampling strategy. |
| Q41699434 | Unusually late-onset mycophenolate mofetil-related colitis |
| Q46873867 | Updated metaanalysis of steroid withdrawal in renal transplant patients on calcineurin inhibitor and mycophenolate mofetil |
| Q35710903 | Use of cyclosporine in renal transplantation |
| Q43175118 | Weaning from corticosteroid therapy after kidney transplantation |
Search more.